Champions Oncology Statistics
Total Valuation
CSBR has a market cap or net worth of $102.81 million. The enterprise value is $106.83 million.
Important Dates
The last earnings date was Wednesday, December 11, 2024, after market close.
| Earnings Date | Dec 11, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CSBR has 13.70 million shares outstanding. The number of shares has increased by 0.25% in one year.
| Current Share Class | 13.70M |
| Shares Outstanding | 13.70M |
| Shares Change (YoY) | +0.25% |
| Shares Change (QoQ) | -0.18% |
| Owned by Insiders (%) | 26.13% |
| Owned by Institutions (%) | 12.04% |
| Float | 5.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 39.50 |
| PS Ratio | 1.90 |
| Forward PS | 3.79 |
| PB Ratio | 150.97 |
| P/TBV Ratio | 297.14 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.99 |
| EV / EBITDA | 74.55 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.75, with a Debt / Equity ratio of 9.95.
| Current Ratio | 0.75 |
| Quick Ratio | 0.70 |
| Debt / Equity | 9.95 |
| Debt / EBITDA | 2.10 |
| Debt / FCF | n/a |
| Interest Coverage | -12.61 |
Financial Efficiency
Return on equity (ROE) is -154.52% and return on invested capital (ROIC) is -2.83%.
| Return on Equity (ROE) | -154.52% |
| Return on Assets (ROA) | -0.82% |
| Return on Capital (ROIC) | -2.83% |
| Revenue Per Employee | $255,100 |
| Profits Per Employee | -$2,848 |
| Employee Count | 210 |
| Asset Turnover | 2.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -40,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +64.58% in the last 52 weeks. The beta is 0.47, so CSBR's price volatility has been lower than the market average.
| Beta (5Y) | 0.47 |
| 52-Week Price Change | +64.58% |
| 50-Day Moving Average | 4.71 |
| 200-Day Moving Average | 4.79 |
| Relative Strength Index (RSI) | 77.44 |
| Average Volume (20 Days) | 61,849 |
Short Selling Information
The latest short interest is 217,885, so 1.59% of the outstanding shares have been sold short.
| Short Interest | 217,885 |
| Short Previous Month | 224,452 |
| Short % of Shares Out | 1.59% |
| Short % of Float | 4.27% |
| Short Ratio (days to cover) | 20.86 |
Income Statement
In the last 12 months, CSBR had revenue of $53.57 million and -$598,000 in losses. Loss per share was -$0.04.
| Revenue | 53.57M |
| Gross Profit | 23.97M |
| Operating Income | -353,000 |
| Pretax Income | -7.31M |
| Net Income | -598,000 |
| EBITDA | 1.43M |
| EBIT | -353,000 |
| Loss Per Share | -$0.04 |
Full Income StatementBalance Sheet
The company has $2.75 million in cash and $6.78 million in debt, giving a net cash position of -$4.02 million or -$0.29 per share.
| Cash & Cash Equivalents | 2.75M |
| Total Debt | 6.78M |
| Net Cash | -4.02M |
| Net Cash Per Share | -$0.29 |
| Equity (Book Value) | 681,000 |
| Book Value Per Share | 0.05 |
| Working Capital | -4.78M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$2.71 million and capital expenditures -$183,000, giving a free cash flow of -$2.89 million.
| Operating Cash Flow | -2.71M |
| Capital Expenditures | -183,000 |
| Free Cash Flow | -2.89M |
| FCF Per Share | -$0.21 |
Full Cash Flow StatementMargins
Gross margin is 44.75%, with operating and profit margins of -0.66% and -1.12%.
| Gross Margin | 44.75% |
| Operating Margin | -0.66% |
| Pretax Margin | -1.19% |
| Profit Margin | -1.12% |
| EBITDA Margin | 2.67% |
| EBIT Margin | -0.66% |
| FCF Margin | n/a |
Dividends & Yields
CSBR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.25% |
| Shareholder Yield | -0.25% |
| Earnings Yield | -0.58% |
| FCF Yield | -2.81% |
Analyst Forecast
The average price target for CSBR is $8.00, which is 6.60% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $8.00 |
| Price Target Difference | 6.60% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 17.68% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on August 12, 2015. It was a reverse split with a ratio of 0.0833333:1.
| Last Split Date | Aug 12, 2015 |
| Split Type | Reverse |
| Split Ratio | 0.0833333:1 |
Scores
CSBR has an Altman Z-Score of -1.05 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.05 |
| Piotroski F-Score | 3 |